1. Home
  2. NCSM vs MXCT Comparison

NCSM vs MXCT Comparison

Compare NCSM & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCS Multistage Holdings Inc.

NCSM

NCS Multistage Holdings Inc.

HOLD

Current Price

$55.99

Market Cap

112.0M

Sector

Energy

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.21

Market Cap

129.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCSM
MXCT
Founded
2006
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.0M
129.6M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
NCSM
MXCT
Price
$55.99
$1.21
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
26.7K
1.2M
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
239.22
N/A
EPS
N/A
N/A
Revenue
$142,471,000.00
$33,026,000.00
Revenue This Year
$5.57
N/A
Revenue Next Year
$4.81
$18.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.73
$0.64
52 Week High
$87.36
$2.40

Technical Indicators

Market Signals
Indicator
NCSM
MXCT
Relative Strength Index (RSI) 60.28 70.95
Support Level $35.60 $0.72
Resistance Level $75.57 $1.77
Average True Range (ATR) 1.91 0.10
MACD 1.70 0.02
Stochastic Oscillator 93.57 77.17

Price Performance

Historical Comparison
NCSM
MXCT

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completion, and field development strategies. The company provides its products and services to E&P companies for use in onshore and offshore wells, predominantly those drilled with horizontal laterals in unconventional and conventional oil and natural gas formations. It also provides tracer diagnostics services and sells products for well construction including casing buoyancy systems, liner hanger systems and toe initiation sleeves, along with certain complementary products from third parties. The company operates in the United States, Canada and other countries, with the majority of its revenue generated from Canada.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: